Clinician perspectives on current issues in lung cancer drug development Journal Article
| Authors: | Waqar, S. N.; Bonomi, P. D.; Govindan, R.; Hirsch, F. R.; Riely, G. J.; Papadimitrakopoulou, V.; Kazandjian, D.; Khozin, S.; Larkins, E.; Dickson, D. J.; Malik, S.; Horn, L.; Ferris, A.; Shaw, A. T.; Jänne, P. A.; Mok, T. S. K.; Herbst, R.; Keegan, P.; Pazdur, R.; Blumenthal, G. M. |
| Article Title: | Clinician perspectives on current issues in lung cancer drug development |
| Abstract: | Recent advances in molecularly targeted therapy and immunotherapy offer a glimmer of hope for potentially realizing the dream of personalized therapy for lung cancer. This article highlights current questions in clinical trial design, enrollment strategies and patient focused drug development, with particular emphasis on unique issues in trials of targeted therapy and immunotherapy. Published by Elsevier Inc. on behalf of International Association for the Study of Lung Cancer. © 2016 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved. |
| Keywords: | lung cancer; immunotherapy; targeted therapy; clinical trials |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 11 |
| Issue: | 9 |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2016-09-01 |
| Start Page: | 1387 |
| End Page: | 1396 |
| Language: | English |
| DOI: | 10.1016/j.jtho.2016.05.009 |
| PROVIDER: | scopus |
| PUBMED: | 27401214 |
| PMCID: | PMC5131641 |
| DOI/URL: | |
| Notes: | Review -- Export Date: 3 October 2016 -- Source: Scopus |
